Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

rPPG

- PMLiVE

Amgen’s Uplizna shown to improve pain and quality of life in attack-free NMOSD patients

The rare autoimmune disease is estimated to affect approximately 6,000 adults in the US

- PMLiVE

Emotive announces brand evolution

The agency’s refreshed visual identity has been launched alongside a new website

- PMLiVE

Medscape Education Demonstrates Strong Education Outcomes at the American Diabetes Association 2024 Conference

Medscape Education presented seven scientific posters at this year’s American Diabetes Association (ADA) conference in Orlando, Florida. These posters highlighted the outcomes of Medscape Education’s continuing medical education programs, which...

Medscape Education

- PMLiVE

Sanofi’s investigational frexalimab shows promise in relapsing MS study

Approximately 2.9 million people worldwide are affected by the neurological disease

- PMLiVE

Celebrating the 2024 Communiqué Awards

The event, now in its 26th year, has become a calendar staple in the healthcare and medcomms industry

- PMLiVE

Johnson & Johnson shares positive phase 3 results for nipocalimab in myasthenia gravis

The rare autoimmune disease is estimated to affect around 700,000 people globally

- PMLiVE

Study shows epilepsy drug could tackle chemotherapy-resistance in stomach cancer

Clinical trials have been launched to evaluate whether Diacomit causes chemotherapy to work again

Mobile Flexibility – Perks of Virtual Medical Education

Unlock the potential of virtual collaboration with mobile flexibility! Discover how the latest technologies enable you to engage in medical education and collaborate from any corner of the globe. Watch...

Impetus Digital

- PMLiVE

GSK and CureVac restructure current mRNA collaboration in deal worth over €1.4bn

The companies have been working together to develop mRNA vaccines for infectious diseases since 2020

- PMLiVE

Sanofi/Regeneron’s Dupixent approved by EMA for uncontrolled COPD in adults

Approximately 220,000 COPD patients in the EU could be eligible for Dupixent treatment

- PMLiVE

Johnson & Johnson announces CHMP recommendation for Balversa in bladder cancer

Up to 20% of patients diagnosed with metastatic urothelial carcinoma have FGFR genetic alterations

EU flag

EC approves Valneva’s single-dose chikungunya vaccine for use in adults

The virus has been identified in over 110 countries in Europe, Asia, Africa and the Americas

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links